Literature DB >> 35869520

Identification of human mitochondrial RNA cleavage sites and candidate RNA processing factors.

Guillermo Carbajosa1, Aminah T Ali1, Alan Hodgkinson2.   

Abstract

BACKGROUND: The human mitochondrial genome is transcribed as long strands of RNA containing multiple genes, which require post-transcriptional cleavage and processing to release functional gene products that play vital roles in cellular energy production. Despite knowledge implicating mitochondrial post-transcriptional processes in pathologies such as cancer, cardiovascular disease and diabetes, very little is known about the way their function varies on a human population level and what drives changes in these processes to ultimately influence disease risk. Here, we develop a method to detect and quantify mitochondrial RNA cleavage events from standard RNA sequencing data and apply this approach to human whole blood data from > 1000 samples across independent cohorts.
RESULTS: We detect 54 putative mitochondrial RNA cleavage sites that not only map to known gene boundaries, short RNA ends and RNA modification sites, but also occur at internal gene positions, suggesting novel mitochondrial RNA cleavage junctions. Inferred RNA cleavage rates correlate with mitochondrial-encoded gene expression across individuals, suggesting an impact on downstream processes. Furthermore, by comparing inferred cleavage rates to nuclear genetic variation and gene expression, we implicate multiple genes in modulating mitochondrial RNA cleavage (e.g. MRPP3, TBRG4 and FASTKD5), including a potentially novel role for RPS19 in influencing cleavage rates at a site near to the MTATP6-COX3 junction that we validate using shRNA knock down data.
CONCLUSIONS: We identify novel cleavage junctions associated with mitochondrial RNA processing, as well as genes newly implicated in these processes, and detect the potential impact of variation in cleavage rates on downstream phenotypes and disease processes. These results highlight the complexity of the mitochondrial transcriptome and point to novel mechanisms through which nuclear-encoded genes can potentially influence key mitochondrial processes.
© 2022. The Author(s).

Entities:  

Keywords:  Mitochondria; QTL; RNA; Transcriptomics

Mesh:

Substances:

Year:  2022        PMID: 35869520      PMCID: PMC9308231          DOI: 10.1186/s12915-022-01373-5

Source DB:  PubMed          Journal:  BMC Biol        ISSN: 1741-7007            Impact factor:   7.364


  64 in total

Review 1.  The human mitochondrial transcriptome and the RNA-binding proteins that regulate its expression.

Authors:  Oliver Rackham; Timothy R Mercer; Aleksandra Filipovska
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-07-09       Impact factor: 9.957

2.  tRNA punctuation model of RNA processing in human mitochondria.

Authors:  D Ojala; J Montoya; G Attardi
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

3.  The Genotype-Tissue Expression (GTEx) project.

Authors: 
Journal:  Nat Genet       Date:  2013-06       Impact factor: 38.330

4.  The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution.

Authors:  Modi Safra; Aldema Sas-Chen; Ronit Nir; Roni Winkler; Aharon Nachshon; Dan Bar-Yaacov; Matthias Erlacher; Walter Rossmanith; Noam Stern-Ginossar; Schraga Schwartz
Journal:  Nature       Date:  2017-10-25       Impact factor: 49.962

5.  Genotype imputation with thousands of genomes.

Authors:  Bryan Howie; Jonathan Marchini; Matthew Stephens
Journal:  G3 (Bethesda)       Date:  2011-11-01       Impact factor: 3.154

6.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

7.  POLRMT regulates the switch between replication primer formation and gene expression of mammalian mtDNA.

Authors:  Inge Kühl; Maria Miranda; Viktor Posse; Dusanka Milenkovic; Arnaud Mourier; Stefan J Siira; Nina A Bonekamp; Ulla Neumann; Aleksandra Filipovska; Paola Loguercio Polosa; Claes M Gustafsson; Nils-Göran Larsson
Journal:  Sci Adv       Date:  2016-08-05       Impact factor: 14.136

8.  Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals.

Authors:  Inge Kühl; Maria Miranda; Ilian Atanassov; Irina Kuznetsova; Yvonne Hinze; Arnaud Mourier; Aleksandra Filipovska; Nils-Göran Larsson
Journal:  Elife       Date:  2017-11-14       Impact factor: 8.140

9.  ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy.

Authors:  Tobias B Haack; Robert Kopajtich; Peter Freisinger; Thomas Wieland; Joanna Rorbach; Thomas J Nicholls; Enrico Baruffini; Anett Walther; Katharina Danhauser; Franz A Zimmermann; Ralf A Husain; Jessica Schum; Helen Mundy; Ileana Ferrero; Tim M Strom; Thomas Meitinger; Robert W Taylor; Michal Minczuk; Johannes A Mayr; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2013-07-11       Impact factor: 11.025

10.  Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis.

Authors:  Fanny Pineau; Davide Caimmi; Milena Magalhães; Enora Fremy; Abdillah Mohamed; Laurent Mely; Sylvie Leroy; Marlène Murris; Mireille Claustres; Raphael Chiron; Albertina De Sario
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.